This industry profile provides a five-year forecast for Canada’s Pharmaceutical Products Industry.
Canada’s Pharmaceutical Products Industry: Industrial Profile Winter 2012
Canada’s Pharmaceutical Products Industry: Industrial Profile Winter 2012
Industry Economic Analysis
$575.00
- Exports—Exports of pharmaceutical products were 6.8 per cent lower through the first 10 months of 2011 than in the same period a year earlier, largely due to fewer shipments to European countries.
- R&D Investment—Steady declines in R&D spending by pharmaceutical companies may result in fewer new drugs being developed.
- Spending on Drugs—Growth in prescription drug spending has fallen steadily over the last decade.
Customers Who Downloaded This Also Liked
6 min read
13 min read
13 min read
9 min read
Require an accessible version of this research?
Upon request, Signal49 Research offers accessible versions of research. Please contact us to request your accessible version.
Learn more about our accessibility policies.
Effective January 26, 2026, AERIC Inc./Signal49 Research discontinued use of ‘The Conference Board of Canada’ name, logo and branding, which had been used by AERIC Inc./Signal49 Research under license from The Conference Board, Inc. The Conference Board, Inc. and its licensees, which are not affiliated with Signal49 Research, own all right, title and interest in THE CONFERENCE BOARD name and trademarks in Canada and have the exclusive right to their use in Canada since January 26, 2026.
